HK1183807A1 - 用於治療神經變性疾病或神經病理性病症的組合物 - Google Patents
用於治療神經變性疾病或神經病理性病症的組合物Info
- Publication number
- HK1183807A1 HK1183807A1 HK13111248.2A HK13111248A HK1183807A1 HK 1183807 A1 HK1183807 A1 HK 1183807A1 HK 13111248 A HK13111248 A HK 13111248A HK 1183807 A1 HK1183807 A1 HK 1183807A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- composition
- neurodegenerative disease
- treating neurodegenerative
- neuropathological condition
- neuropathological
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34450510P | 2010-08-10 | 2010-08-10 | |
PCT/CN2011/001325 WO2012019435A2 (en) | 2010-08-10 | 2011-08-10 | Composition for treating neurodegenerative disease or neuropathological condition |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1183807A1 true HK1183807A1 (zh) | 2014-01-10 |
Family
ID=45567971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13111248.2A HK1183807A1 (zh) | 2010-08-10 | 2013-10-03 | 用於治療神經變性疾病或神經病理性病症的組合物 |
Country Status (4)
Country | Link |
---|---|
US (1) | US9283204B2 (zh) |
CN (1) | CN103200949B (zh) |
HK (1) | HK1183807A1 (zh) |
WO (1) | WO2012019435A2 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013235422B2 (en) * | 2012-03-19 | 2016-12-15 | Buck Institute For Research On Aging | APP specific BACE inhibitors (ASBIs) and uses thereof |
CN104546825A (zh) * | 2014-12-30 | 2015-04-29 | 上海中医药大学 | 高良姜素的医药用途 |
EP3257518A1 (en) | 2016-01-26 | 2017-12-20 | Industrial Technology Research Institute | A pharmaceutical composition for treating or alleviating autoimmune-related diseases and use of an acitive ingredient in the pharmaceutical composition |
CN110237066B (zh) * | 2018-03-07 | 2022-03-29 | 上海市生物医药技术研究院 | 3-甲氧基黄酮及其衍生物在制备治疗或预防肾病的药物中的应用 |
CN112891337A (zh) * | 2021-03-26 | 2021-06-04 | 河北医科大学 | 高良姜素及其衍生物在制备预防和治疗神经系统疾病药物中的用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100523562B1 (ko) * | 2001-10-29 | 2005-10-25 | 한국과학기술연구원 | 손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물 |
CN100367970C (zh) * | 2005-01-24 | 2008-02-13 | 中国人民解放军第二军医大学 | 山奈酚衍生物用于制备防治痴呆药物的用途 |
CN100415228C (zh) * | 2005-06-16 | 2008-09-03 | 广州汉方现代中药研究开发有限公司 | 含高良姜素的药物及其制备方法 |
KR100946789B1 (ko) * | 2008-01-15 | 2010-03-11 | 강원대학교산학협력단 | 치매의 개선 및 치료 효과와 인지기억능 향상효과를 가지는양강추출물 |
KR101068561B1 (ko) * | 2008-03-31 | 2011-09-28 | 경희대학교 산학협력단 | 퇴행성 뇌신경질환 예방 또는 치료용 계지, 지모 및 양강의 생약 혼합 추출물의 제조 방법 |
-
2011
- 2011-08-10 WO PCT/CN2011/001325 patent/WO2012019435A2/en active Application Filing
- 2011-08-10 US US13/814,555 patent/US9283204B2/en active Active
- 2011-08-10 CN CN201180037552.4A patent/CN103200949B/zh active Active
-
2013
- 2013-10-03 HK HK13111248.2A patent/HK1183807A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2012019435A3 (en) | 2013-05-10 |
US9283204B2 (en) | 2016-03-15 |
WO2012019435A2 (en) | 2012-02-16 |
CN103200949B (zh) | 2016-10-12 |
US20130137762A1 (en) | 2013-05-30 |
CN103200949A (zh) | 2013-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2611765A4 (en) | METHODS OF TREATING NEURODEGENERATIVE DISEASES | |
GB201021103D0 (en) | New compounds for the treatment of neurodegenerative diseases | |
EP2621497A4 (en) | ASSOCIATION TREATMENT FOR ROSE ACNE | |
HK1202248A1 (zh) | 用於治療神經退行性疾病的組合物和方法 | |
HK1202246A1 (zh) | 用於治療神經退行性疾病的組合物和方法 | |
ZA201204845B (en) | Agents for treating disease | |
HK1207585A1 (zh) | 含有馬鞭草烯酮衍生物的神經退行性疾病治療或者預防用藥物組合物 | |
EP2688402A4 (en) | METHODS FOR THE TREATMENT OR PREVENTION OF UROLOGIC INFLAMMATION | |
IL221415A0 (en) | Compounds useful for treating neurodegenerative disorders | |
SG11201403265VA (en) | Medical composition for preventing or treating amyloid β peptide related diseases or conditions | |
EP2774917A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES | |
HK1183807A1 (zh) | 用於治療神經變性疾病或神經病理性病症的組合物 | |
HK1207579A1 (zh) | 用於預防或治療心臟疾病的組合物 | |
EP2723339A4 (en) | COMPOUNDS FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES AND OTHER NEURODEGENERATIVE DISEASES | |
EP2689777A4 (en) | PHARMACEUTICAL COMPOSITION FOR TREATING HEPATIC DISEASES | |
ZA201201894B (en) | Pharmaceutical combination for treating tumor | |
EP2563353A4 (en) | COMPOUNDS FOR ANTIFUNGAL TREATMENT | |
PL2663318T3 (pl) | Kompozycja farmaceutyczna do leczenia raka | |
GB2486713B (en) | Pharmaceutical composition for treating urinary system disorders | |
EP2785343A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYPERLIPIDEMIA | |
EP2673239A4 (en) | BIOCIDAL COMPOSITION FOR TREATING WATER | |
GB2489207B (en) | Waste treatment | |
GB201009094D0 (en) | Compounds for the treatment of closridium difficile-associated disease | |
GB0911469D0 (en) | Compounds to treat neurodegenerative disease | |
AU2011900437A0 (en) | Biocidal Composition for Treating Water |